Month: March 2022

Not for distribution to U.S. news wire services or dissemination in the United States. Vancouver, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — St. James Gold Corp. (the “Company”) (TSXV: LORD) (OTCQB: LRDJF) (FSE: BVU3) is pleased to announce that, effective immediately, the Company has appointed Leigh Hughes to its board of Directors. Mr. Hughes is an entrepreneur and venture capitalist who has over 20 years’ experience working with private and public companies across the globe, in particular North America, Australia and the Asia Pacific Region. Mr. Hughes is the Founder of COMVERJ Ventures which helps clients identify opportunities for change in the fields of mergers & acquisitions, capital markets, business strategy and innovation. COMVERJ Ventures has worked with numerous public companies in United States, Canada,...

Study published in the IJSS shows Surgalign product to be a reliable solution for SIJ dysfunction DEERFIELD, Ill., March 24, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the publication of results from EVoluSIon (EVSI), a large, prospective, multi-center study of clinical outcomes following minimally invasive sacroiliac joint (SIJ) fusion with decortication. Published in the February 2022 issue of the International Journal of Spine Surgery, Clinical Outcomes Following Minimally Invasive Sacroiliac Joint Fusion with Decortication: The EVoluSIon Clinical Study1, reports 12-month clinical outcomes following minimally invasive SIJ fusion using the SImmetry Sacroiliac Joint Fusion...

Dublin Office Named as One of Ireland’s Best Mid-Sized Workplaces Overall and a Best Workplace for Women SAN FRANCISCO, March 24, 2022 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading destination for learning and teaching online, today announced that Great Place to Work® has honored the company as number 5 on the list of Ireland’s Best Medium Workplaces in 2022. Additionally, Udemy’s Dublin office has been recognised as a 2022 Best Workplace for Women, which recognises top organisations with women-friendly policies and benefits, on top of creating a positive and supportive workplace. “We’re thrilled to be ranked No. 5 Best Midsize Workplace in Ireland and recognised as one of the Best Workplaces for Women,” said Bill O’Shea, Udemy Vice President of EMEA. “These accolades are a testament to our talented Udemates and our incredible...

Company poised for continued growth in a $6+ billion market¹ RALEIGH, N.C., March 24, 2022 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), has signed an agreement with Corteva Agriscience (NYSE: CTVA) that expands the opportunity for MBI technologies to be used on seeds sold by Corteva for row crops globally. Marrone Bio currently provides seed treatment solutions to Corteva for use throughout Europe. MBI introduced biological seed treatments as a sustainable alternative to control yield-robbing pests in the United States in 2017. Those offerings expanded to include plant health solutions, particularly in the European market, with the acquisition of Pro Farm in 2019. Today, more than 30% of MBI’s annual revenues come from seed technologies used on approximately 35 million acres of major row crops such as corn,...

Lexington, Kentucky, March 24, 2022 (GLOBE NEWSWIRE) — Rubicon Technologies, LLC (“Rubicon” or “the Company”), a digital marketplace for waste and recycling and provider of innovative software-based solutions for businesses and governments worldwide, and Founder SPAC (Nasdaq: FOUN) (“Founder”), a publicly-traded special purpose acquisition company, today announced Rubicon will be hosting a Virtual Analyst & Investor Day on Tuesday, April 12, 2022 at 11:00 am EDT. During the two-hour virtual event, members of the Rubicon and Founder SPAC executive teams will provide an overview of the Company, an established global leader in providing cloud-based waste and recycling solutions to businesses and governments around the world. In addition, the formal presentation will be followed by a live question and answer session hosted by...

DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that data from its pivotal Phase 3 study of berdazimer gel 10.3% (SB206) for the treatment of molluscum contagiosum was selected for an oral presentation at a late-breaker session at the American Academy of Dermatology’s (AAD) 2022 Annual Meeting. Details of the abstract presentation are as follows:Title: Berdazimer 10.3% Gel (SB206): A Novel, Topical Nitric Oxide Releasing Medication: Results from a Pivotal Phase 3 Study in Patients (Children and Adults) with Molluscum ContagiosumSession:   Clinical Studies/PediatricDate & Time: March 26, 2022, at 10:20am ETLocation: Rm. 253AThe presentation will be given by Dr. John Browning M.D., F.A.A.D, F.A.A.P., MBA, Adjunct Associate Professor of Pediatrics...

$NSAV Announces Launch of HIVE, the First Blockchain Home Mining Device that Can Mine Multiple Tokens HIVE, the world’s first blockchain home mining deviceLondon, England, March 24, 2022 (GLOBE NEWSWIRE) — Net Savings Link, Inc. (OTC Pink: NSAV), a cryptocurrency, blockchain and digital asset technology company, today announced, in partnership with Metaverse Network LLC. (MNC) https://metaversenetwork.llc/, the launch of HIVE, the world’s first blockchain home mining device able to mine multiple tokens https://hive.codes/. New developer listings can park with our Blockchain and can experience “1 DEVICE ALL MINE” (multiple chain mining). Developers can publish their regulatory subscription conditions in our HIVE App’s CRYPTO STORE. When subscribers synchronize selected CRYPTO to mine, they will be able to mine their selections,...

MELVILLE, N.Y., March 24, 2022 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of diverse business continuity solutions for disaster-recovery, cloud infrastructure, cyber-security and data analytics solutions, today announced that it plans to host a conference call at 10:00 am ET on Thursday, March 31, 2022 to discuss the company’s financial results for the 2021 fiscal year ended December 31, 2021, as well as corporate progress and other developments. The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or for international callers +1 973-528-0011 and using entry code: 283625. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2763/44979, or on the Company’s Investor Relations section of the website, ir.datastoragecorp.com. A...

Delivers High-Demand Specialized Talent and Strategic Managed Services Globallyibex Unveils Augment by ibex for On-Demand Staff Augmentation and Managed Services Augment by ibex provides specialized dedicated talent for high-demand professional and administration functions, ranging from IT and engineering to cyber security, marketing, data analytics, and data science.WASHINGTON, March 24, 2022 (GLOBE NEWSWIRE) — ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced the launch of Augment by ibex, the company’s staff augmentation and managed services offering. Augment by ibex provides specialized dedicated talent for high-demand professional and administration functions, ranging from IT and engineering to cyber security, marketing,...

LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announced today that the Company will host a conference call at 11:00 a.m. ET on Thursday, March 31, 2022 to discuss financial results for the year ended December 31, 2021 and provide an update on product development programs with GEN-1, a DNA-based immunotherapy, currently in Phase II development for the localized treatment of advanced ovarian cancer and PLACCINE, a proprietary synthetic, non-viral vaccine delivery technology currently in preclinical studies. Celsion has two platform technologies for the development of novel nucleic acid-based immunotherapies and next generation infectious vaccines. To participate in the call, interested...